Wen kai Fu

Ms. Wen kai Fu

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 November 2025 in Cell Proliferation
Verified
Journal Article
Open access
WFWen kai Fu
Wen kai Fu
JWJunqi Wang
Junqi Wang
NLNan Lu
Nan Lu
ZGZhijiang Guo
Zhijiang Guo
SOSang Bing Ong
Sang Bing Ong
MMMiao Meng
Miao Meng
Mitochondrial quality control (MQC) impairment plays a central role in driving the pathogenesis of metabolism-associated steatotic liver disease (MASLD). Specifically, this is manifested as reduced mitophagy; increased mitochondrial fission and decreased fusion; and impaired mitochondrial biogenesis. Key pathological mechanisms of MASLD, such as hepatocyte apoptosis, pyroptosis, and ferroptosis, are activated under the influence of factors including free fatty acids (FFAs), oxidative stress, NLRP3 inflammasome activation, and gut microbiota imbalance. Meanwhile, the letter also lists novel potential therapeutic strategies targeting these pathways, including autophagy enhancers, mitochondrial dynamics regulators, biogenesis promoters, and ferroptosis inhibitors.

22 May 2026 in Acta Diabetologica
Verified
Journal Article
Closed access
PDF file
WFWen kai Fu
Wen kai Fu
JWJunqi Wang
Junqi Wang
ZGZhijiang Guo
Zhijiang Guo
SOSang Bing Ong
Sang Bing Ong
YGYong Gao
Yong Gao
XCXing Chang
Xing Chang